🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseFibrosis regression on GLP-1 — need advice Page 2

Fibrosis regression on GLP-1 — need advice

COA_Karl Tue, Mar 24, 2026 at 4:16 AM 12 replies 679 viewsPage 2 of 3
lori_vegas
Member
378
1,678
Aug 2024
Las Vegas, NV
Mar 24, 2026 at 7:06 AM#6

Saving this for reference. Top-tier content.

Last edited: Mar 24, 2026 at 9:06 AM
17 15amy_econ_NJ, bbq_ray_KC, oliver_london and 14 others
Reply Quote Save Share Report
JessicaH_TX
Senior Member
4,123
13,456
Dec 2023
Houston, TX
Mar 24, 2026 at 7:23 AM#7

Slightly tangential to Fibrosis regression on but KristenIndy reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

35 15sarah_TO, wendy_avl, jason_paloalto and 32 others
Reply Quote Save Share Report
TomTeleRx
Member
189
678
Feb 2025
Delaware
Mar 24, 2026 at 7:40 AM#8

+1 to KristenIndy. Especially the point about "A few questions about your Fibrosis regr..." — I have seen the same in my own experience with Fibrosis regression on.

Last edited: Mar 24, 2026 at 8:40 AM
41 20LibrarianMeg, bri_stats, pete_manc_UK and 38 others
Reply Quote Save Share Report
KetoKyle
Member
678
3,456
Jul 2024
Utah
Mar 24, 2026 at 7:57 AM#9

Dr.EndoIndy — that is really helpful context on Fibrosis regression on. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

32 24Dr.GastroMayo, JakeBK_lifts, DerekSJ_a1c and 29 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Mar 24, 2026 at 8:14 AM#10

To answer TomTeleRx's question specifically:

From a clinical standpoint, Fibrosis regression on GLP-1 is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

25 21carl_compliance, DanielChem_CHI, marco_milano and 22 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register